Cargando…
Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis
Background: Several recent studies have reported the reliable prognostic effect of hematological biomarkers in various tumors. Yet, the prognostic value of these hematological markers in soft tissue sarcoma (STS) remains inconclusive. Thus, the aim of this meta-analysis was to check the effect of he...
Autores principales: | Li, Long-Qing, Bai, Zhen-Hua, Zhang, Liang-Hao, Zhang, Yan, Lu, Xin-Chang, Zhang, Yi, Liu, Yong-Kui, Wen, Jia, Li, Jia-Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002470/ https://www.ncbi.nlm.nih.gov/pubmed/32082998 http://dx.doi.org/10.3389/fonc.2020.00030 |
Ejemplares similares
-
Pharmacogenomics Biomarkers of Soft Tissue Sarcoma Therapies
por: Caruso, Chiara, et al.
Publicado: (2020) -
Assessment of Efficiency and Safety of Apatinib in Advanced Bone and Soft Tissue Sarcomas: A Systematic Review and Meta-Analysis
por: Long, Zuoyao, et al.
Publicado: (2021) -
Nanomaterial Technology and Soft Tissue Sarcomas
por: Zhou, Changkai, et al.
Publicado: (2022) -
Impact of Limb Salvage on Prognosis of Patients Diagnosed With Extremity Bone and Soft Tissue Sarcomas
por: Yu, Kaixu, et al.
Publicado: (2022) -
Heterogeneity of Soft Tissue Sarcomas and Its Implications in Targeted Therapy
por: Du, Xin-Hui, et al.
Publicado: (2020)